Bite Acquisition Corp. - BITE STOCK NEWS

Bite Acquisition Corp. (NYSE: BITE) announced its transfer of listing from the New York Stock Exchange to NYSE American, effective February 13, 2023. The company will continue trading under the same ticker symbols: BITE, BITE.U, and BITE WS. As a SPAC, Bite focuses on potential mergers in the restaurant sector across North America. The transition aims to enhance trading liquidity and access to capital for future business combinations.

Bite Acquisition Corp. (NYSE: BITE) announced plans to transfer its common stock, units, and warrants listing from the New York Stock Exchange to NYSE American LLC, effective February 13, 2023. The company's ticker symbols will remain the same: BITE, BITE.U, and BITE WS. As a special purpose acquisition company (SPAC), Bite Acquisition Corp. focuses on mergers and business combinations, particularly in the restaurant sectors across North America. This move aims to enhance trading opportunities for investors as the company prepares for future business ventures.

Bite Acquisition Corp. (NYSE: BITE) announced the resignation of Board Chair Rafael Aguirre and Independent Director Randall Hiatt, effective December 31, 2022. CEO Alberto Ardura will replace Aguirre as Chair. The company expressed gratitude for their contributions while planning to explore business combinations beyond the restaurant sector, broadening its targets. The search for a new independent board member is underway. The company, formed for mergers and acquisitions, aims to identify opportunities in traditional and non-traditional restaurant sectors across North America.

Bite Acquisition Corp. (NYSE: BITE.U, BITE, BITE.WS) announced an amendment to its proxy statement related to a special meeting on December 15, 2022. The amendment alters the Extension Payment calculation to $0.05 per public share, capped at $150,000, allowing for extensions of up to six months. If stockholders approve the Early Termination Proposals, all public shares will be redeemed by December 22, 2022, due to the failure to complete a business combination within the charter's timeframe. The per-share redemption price is expected to be ~$10.00, pending approval, after which the company may proceed with dissolution.

Alurx has appointed Dr. Erum Ilyas, a Board Certified Dermatologist, and Dr. Alexis Peraino, a Board Certified Internist, to its Medical & Expert Council. Both doctors bring extensive experience and a commitment to wellness and disease prevention. Dr. Ilyas is recognized for her work in dermatology and has founded a line of sun-protective clothing. Dr. Peraino focuses on exercise physiology and preventive care. Together, they will contribute to Alurx's mission of developing wellness products and providing expert guidance.

Bite Acquisition Corp. announced the partial exercise of the over-allotment option related to its initial public offering (IPO), resulting in the issuance of an additional 2,500,000 units at $10.00 each. This brings the total units issued to 20,000,000, totaling $200,000,000. Each unit includes one share of common stock and one redeemable warrant. The units are listed on the NYSE under ticker symbol 'BITE.U,' and the common stock and warrants are expected to trade under 'BITE' and 'BITE WS' respectively.

Bite Acquisition Corp. announced the pricing of its upsized initial public offering (IPO) of 17,500,000 units at $10.00 per unit on February 11, 2021. Trading is expected to commence on February 12, 2021, under the symbol 'BITE.U' on the New York Stock Exchange. Each unit consists of one share of common stock and a half warrant, with whole warrants exercisable at $11.50 each. The IPO aims to merge or acquire businesses, focusing on the restaurant sector in North America. The offering is set to close around February 17, 2021, pending customary conditions.